Clinical perspectives of PSMA PET/MRI for prostate cancer

about

Clinical perspectives of PSMA PET/MRI for prostate cancer

Item

http://www.wikidata.org/entity/Q57071079

description

scientific article published on 21 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Clinical perspectives of PSMA PET/MRI for prostate cancer

@en

Clinical perspectives of PSMA PET/MRI for prostate cancer

@nl

type

Item

label

Clinical perspectives of PSMA PET/MRI for prostate cancer

@en

Clinical perspectives of PSMA PET/MRI for prostate cancer

@nl

prefLabel

Clinical perspectives of PSMA PET/MRI for prostate cancer

@en

Clinical perspectives of PSMA PET/MRI for prostate cancer

@nl

P1476

Clinical perspectives of PSMA PET/MRI for prostate cancer

@en

P2093

Felipe de Galiza Barbosa

http://www.w3.org/2001/XMLSchema#string

Giovanni Guido Cerri

http://www.w3.org/2001/XMLSchema#string

José Flávio Gomes Marin

http://www.w3.org/2001/XMLSchema#string

Rafael Fernandes Nunes

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

P304

e586s

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6061/CLINICS/2018/E586S

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Alberto Buchpiguel

Marcelo Queiroz

P5008

ScienceSource

P577

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30281701

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

multimodal imaging

Anzim

P932

6142859

http://www.w3.org/2001/XMLSchema#string